Joanne M. Donovan sold $926K of Edgewise Therapeutics (EWTX)

Executed Apr 1, disclosed Apr 2, 1 day later.

Value, as filed

$926K

28,662 sh × $32.31

Executed

Apr 1

the trade date, as filed

Disclosed

Apr 2

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Joanne M. Donovan CMO profile →

Joanne M. Donovan (CMO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Edgewise Therapeutics, Inc. (EWTX). The largest single filing was $2.1M of EWTX (55,230 sh across 2 lots, as filed), executed May 4.

The name

EWTX

Edgewise Therapeutics, Inc. EWTX · Healthcare · 23 filings in 24 months ticker →

Healthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Joanne M. Donovan in EWTX

EWTXSALE Edgewise Therapeutics, Inc. $372K
8,537 sh across 3 lots
Exec Aug 12
Filed Aug 14 · 4:54 PM ET EWTXSALE Edgewise Therapeutics, Inc. $2.1M
55,230 sh across 2 lots
Exec May 4
Filed May 5 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. $685K
21,338 sh × $32.12
Exec Mar 31
Filed Mar 31 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. $507K
16,358 sh across 2 lots
Exec Mar 27
Filed Mar 30 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. $691K
25,000 sh × $27.63
Exec Jan 28 2025
Filed Jan 30 2025 · 5:30 PM ET